Dr. Della Valle’s Paper Wins The Knee Society’s Mark Coventry, MD Award

Dr. Della Valle’s paper entitled, “A Multi-center Randomized Clinical Trial of Tranexamic Acid in Revision Total Knee Arthroplasty: Does the Dosing Regimen Matter?” has won The Knee Society’s Mark Coventry, MD Award.

Revision total knee arthroplasty is a complex surgery that has a higher risk of blood loss than primary total knee arthroplasty. In this multi-center, prospective, randomized controlled trial we evaluated different dosing and administration routes of tranexamic acid, a medication shown to reduce blood loss after primary and revision total knee arthroplasty. This study found that all tranexamic dosing regimens were similarly effective methods of blood management in revision total knee arthroplasty. This study supports that surgeons should consider using the lowest effective dose and the least costly regimen for tranexamic acid use in revision total knee arthroplasty.

The paper will be presented at The Knee Society/AAHKS Specialty Day program (AAOS 2019 Annual Meeting) on Saturday, March 16, in Las Vegas, NV.